Benzodiazepines in clinical and forensic analysis

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F07%3A10223813" target="_blank" >RIV/61989592:15110/07:10223813 - isvavai.cz</a>

Result on the web

—

DOI - Digital Object Identifier

—

Result language

angličtina

Original language name

Benzodiazepines in clinical and forensic analysis

Original language description

The results presented here show that despite the wellknown advantages of immunoassays in screening analysis of urine for drugs of abuse (including BZD), it is necessary to confirm practically all benzodiazepine results obtained in this way. Immunochemical screening of urine should be always followed by identification of BZD and their metabolites in urine or better in both urine and gastric contents using e.g. TLC, GC-MS and subsequent BZD confirmation/quantitation in blood, for example using GC-ECD. Only complex toxicological analysis of biological material (urine, gastric contents and blood) using immunochemical as well as chromatographical methods permits toxicological laboratories to give valid interpretation of results, thus contributing to objective evaluation of the level of intoxication in forensic as well as clinical practice.

Czech name

—

Czech description

—

Type

J_x - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

CEP classification

CB - Analytical chemistry, separation

OECD FORD branch

—

Project

—

Continuities

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year

2007

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

Chemické listy

ISSN

0009-2770

e-ISSN

—

Volume of the periodical

73-310

Issue of the periodical within the volume

101

Country of publishing house

CZ - CZECH REPUBLIC

Number of pages

3

Pages from-to

141-143

UT code for WoS article

—

EID of the result in the Scopus database

—